Transcriptional activation domain of p300/CBP-associated factor(P/CAF)
p300/CBP相关因子(P/CAF)转录激活域
基本信息
- 批准号:09672226
- 负责人:
- 金额:$ 1.73万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In eukaryores, transcription of mRNA-encoding classII genes involves the ordered recruitment of general factors and the RNA polymerase II holoenzyme into the basal transcription pre-initiation complex on promoter.The transcription is efficiently enhanced by transcriptional activators which bind to specific DNA sequences outside of the core promoter.Sequence-specific activators work in conjunction with other factors which do not bind DNA directly.These factors are termed co-activators and are recruited to promoters via their interaction with the DNA-bound transcription factors.P/CAF was originally identified as a p300/CBP-binding protein by virtue of its sequence similarity to a yeast histone acetyltransferase (HAT), namely yGCN5.In addition, P/CAF interacts with other co-activators such as ACIR and SRC-1 which are also HAT.In this study, I focused on the function of P/CAF in the transcriptional regulation and investigated the transcriptional activation domain of P/CAF.In order to examine the activation function of P/CAF, I expressed various regions of P/CAF as GALA DNA binding domain in yeast.P/CAF indeed worked as a transcriptional activator protein in yeast and the region of amino acids 366-654 was necessary for activation function.As this region is identical to the HAT domain, the activation function of P/CAF might be related to the acetylation of histones.On the other hand, the interaction of P/CAF with CBP was independent on the activation domain. The complex formation of co-activators in vitro was also examined using surface plasmon resonance anaysis.
在真核生物中,编码 mRNA 的 II 类基因的转录涉及将通用因子和 RNA 聚合酶 II 全酶有序招募到启动子上的基础转录前起始复合物中。转录激活剂可与核心启动子外部的特定 DNA 序列结合,从而有效增强转录。序列特异性激活剂与不直接结合 DNA 的其他因子协同工作。这些因子 被称为共激活因子,并通过与 DNA 结合的转录因子相互作用而被招募至启动子。P/CAF 最初因其与酵母组蛋白乙酰转移酶 (HAT)(即 yGCN5)的序列相似性而被鉴定为 p300/CBP 结合蛋白。此外,P/CAF 与其他共激活因子(如 ACIR 和 SRC-1)相互作用,这些共激活因子也是 HAT。 在本研究中,我重点研究了P/CAF在转录调控中的功能,并研究了P/CAF的转录激活结构域。为了检验P/CAF的激活功能,我将P/CAF的各个区域表达为酵母中的GALA DNA结合结构域。P/CAF确实在酵母中作为转录激活蛋白,并且氨基酸366-654的区域是激活功能所必需的。由于该区域 与HAT结构域相同,P/CAF的激活功能可能与组蛋白的乙酰化有关。另一方面,P/CAF与CBP的相互作用不依赖于激活结构域。还使用表面等离子体共振分析检查了体外共激活剂的复合物形成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIKAWA Jun-ichi其他文献
NISHIKAWA Jun-ichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIKAWA Jun-ichi', 18)}}的其他基金
Induction mechanism of imposex in marine gastropods by retinoids
类维生素A诱导海洋腹足动物强行性的机制
- 批准号:
21590143 - 财政年份:2009
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of endocrine disruptors on nuclear receptor superfamily.
内分泌干扰物对核受体超家族的影响。
- 批准号:
14370764 - 财政年份:2002
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of transgenic medaka for detecting endocrine disruptors
开发用于检测内分泌干扰物的转基因青鳉
- 批准号:
11839014 - 财政年份:1999
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 1.73万 - 项目类别:
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 1.73万 - 项目类别:
Development of first-in-class histone acetyltransferase (HAT) activators for precision targeting of epigenetic derangements in lymphoma
开发一流的组蛋白乙酰转移酶 (HAT) 激活剂,用于精确靶向淋巴瘤表观遗传紊乱
- 批准号:
10470919 - 财政年份:2018
- 资助金额:
$ 1.73万 - 项目类别:
Development of first-in-class histone acetyltransferase (HAT) activators for precision targeting of epigenetic derangements in lymphoma
开发一流的组蛋白乙酰转移酶 (HAT) 激活剂,用于精确靶向淋巴瘤表观遗传紊乱
- 批准号:
10241324 - 财政年份:2018
- 资助金额:
$ 1.73万 - 项目类别:
Development of first-in-class histone acetyltransferase (HAT) activators for precision targeting of epigenetic derangements in lymphoma
开发一流的组蛋白乙酰转移酶 (HAT) 激活剂,用于精确靶向淋巴瘤表观遗传紊乱
- 批准号:
9790953 - 财政年份:2018
- 资助金额:
$ 1.73万 - 项目类别:
In Vivo Epigenome Editing with CRISPR-Based Histone Acetyltransferase Transgenic Mice
使用基于 CRISPR 的组蛋白乙酰转移酶转基因小鼠进行体内表观基因组编辑
- 批准号:
9132500 - 财政年份:2016
- 资助金额:
$ 1.73万 - 项目类别:
In Vivo Epigenome Editing with CRISPR-Based Histone Acetyltransferase Transgenic
使用基于 CRISPR 的转基因组蛋白乙酰转移酶进行体内表观基因组编辑
- 批准号:
9895699 - 财政年份:2016
- 资助金额:
$ 1.73万 - 项目类别:
Regulation of Histone Acetyltransferase Stability In Sepsis
脓毒症中组蛋白乙酰转移酶稳定性的调节
- 批准号:
9107899 - 财政年份:2015
- 资助金额:
$ 1.73万 - 项目类别:
Regulation of Histone Acetyltransferase Stability In Sepsis
脓毒症中组蛋白乙酰转移酶稳定性的调节
- 批准号:
8938959 - 财政年份:2015
- 资助金额:
$ 1.73万 - 项目类别:














{{item.name}}会员




